| Particulars |
|
|
|
| Company Name
| Piramal Pharma Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
1,329.25 |
B.V. (₹) |
61.30 |
| Sales(₹ Cr.) |
4,782.01 |
NP (₹ Cr.) |
773.87 |
| NP Var% |
12.00 |
Div% |
0.00 |
| CPS(₹) |
7.70 |
EPS (₹) |
5.80 |
| Traded Value(₹ Lakhs) |
181.33 |
52 Week High |
221.00 |
| 52 Week Low |
133.00 |
Price BSE |
176.00 |
| Price NSE |
176.00 |
Market Capital (₹ Cr.) |
23,328.30 |
| P/C Ratio |
22.70 |
P/E Ratio |
30.20 |
| Price Vs.BV |
2.87 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
1,489.06 |
| NP(₹ Cr.) |
313.33 |
NP Var % |
13.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
4,897.03 |
| OPM |
20.67 |
NP |
642.75 |
| NP Var% |
12.13 |
EPS |
5.82 |
| PE |
30.15 |
|
|